DayOne Accelerator — HealthTech & TechBio
DayOne (Basel)
HIGH
T3
Startup
Strategy Notes
No equity taken, no fees. 3-month hybrid program. Basel = Roche/Novartis/Novartis network. Drug discovery / pharma AI / TechBio track is direct fit. Pre-seed eligible. Target: apply May 2027 once AUROC milestone and pilot data available.
Key Materials
Online application form, startup pitch video (3 min), technical overview, team profile
Gate / Eligibility
2026 cohort closed. Apply for 2027. Minimum: MVP or validated POC.